Abstract
In this article, we provide a brief description of the current understanding of aberrant signaling pathways in meningiomas. Cell signaling pathways are responsible for cellular differentiation, development, growth, growth inhibition, and death. In fact, signaling pathways can affect multiple intracellular functions, including those responsible for development, angiogenesis, and apoptosis. Ultimately, a further understanding of the signaling pathways involved in meningioma tumorigenesis will lead to the development and application of novel molecular treatments, such as small molecule inhibitors or interfering ribonucleic acid technologies.
Similar content being viewed by others
References
Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088–1095
Burger P, Scheithauer B, Vogel F (2002) Surgical pathology of the nervous system and its coverings. Churchill Livingstone, Philadelphia
Al-Rodhan R, Laws E (1991) The history of intracranial meningiomas. In: Al-Mefty O (ed) Meningiomas. Raven Press, New York, pp 1–6
Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19(5):E9
Ragel B, Jensen RL (2003) New approaches for the treatment of refractory meningiomas. Cancer Control 10:148–158
Tsukita S, Oishi K, Sato N, Sagara J, Kawai A (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391–401
Gerber MA, Bahr SM, Gutmann DH (2006) Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling. Cancer Res 66:5295–5303
Lee JH, Sundaram V, Stein DJ, Kinney SE, Stacey DW, Golubic M (1997) Reduced expression of schwannomin/merlin in human sporadic meningiomas. Neurosurgery 40:578–587
Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF (2000) Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 9:1495–1500
Ragel B, Jensen R (2003) Pathophysiology of meningiomas. Semin Neurosurg 14:169–186
James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, Gusella JF, Ramesh V (2009) NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol 29:4250–4261
Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH (2000) Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 59:872–879
Kittiniyom K, Gorse K, Dalbegue F, Lichy J, Taubenberger J, Newsham I (2001) Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression. Breast Cancer Res 3:192–198
Gutmann DH, Hirbe AC, Huang ZY, Haipek CA (2001) The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol Dis 8:266–278
Robb VA, Gerber MA, Hart-Mahon EK, Gutmann DH (2005) Membrane localization of the U2 domain of protein 4.1B is necessary and sufficient for meningioma growth suppression. Oncogene 24:1946–1957
Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Investig 91:153–159
Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M, Alitalo K (1995) Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146:368–378
Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189–1193
Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, Nose T (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56:2185–2190
Goldman CK, Bharara S, Palmer CA, Vitek J, Tsai JC, Weiss HL, Gillespie GY (1997) Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40:1269–1277
Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM (1996) Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85:1095–1101
Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026
Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergun S, Westphal M (2000) Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 46:938–947 (discussion 947–948)
Shono T, Inamura T, Torisu M, Suzuki SO, Fukui M (2000) Vascular endothelial growth factor and malignant transformation of a meningioma: case report. Neurol Res 22:189–193
Dietzmann K, von Bossanyi P, Warich-Kirches M, Kirches E, Synowitz HJ, Firsching R (1997) Immunohistochemical detection of vascular growth factors in angiomatous and atypical meningiomas, as well as hemangiopericytomas. Pathol Res Pract 193:503–510
Nishikawa R, Cheng SY, Nagashima R, Huang HJ, Cavenee WK, Matsutani M (1998) Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol 96:453–462
Pietsch T, Valter MM, Wolf HK, von Deimling A, Huang HJ, Cavenee WK, Wiestler OD (1997) Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93:109–117
Jensen RL, Soleau S, Bhayani MK, Christiansen D (2002) Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg 97:658–667
Yamasaki F, Yoshioka H, Hama S, Sugiyama K, Arita K, Kurisu K (2000) Recurrence of meningiomas. Cancer 89:1102–1110
Bitzer M, Opitz H, Popp J, Morgalla M, Gruber A, Heiss E, Voigt K (1998) Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien) 140:333–340
Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K (1999) Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer 85:936–944
Tsai JC, Hsiao YY, Teng LJ, Shun CT, Chen CT, Goldman CK, Kao MC (1999) Regulation of vascular endothelial growth factor secretion in human meningioma cells. J Formos Med Assoc 98:111–117
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604–4613
Richard DE, Berra E, Pouyssegur J (1999) Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 266:718–722
Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510–5514
Harland SP, Kuc RE, Pickard JD, Davenport AP (1995) Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol 26(Suppl 3):S408–S411
Kitagawa N, Tsutsumi K, Niwa M, Himeno A, Yamashita K, Shibata S, Taniyama K, Kurihara M, Kawano T, Yasunaga A et al (1994) Expression of a functional endothelin (ETA) receptor in human meningiomas. J Neurosurg 80:723–731
Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton CJ, Lange M, Uhl E, Weindl A, Stalla GK (1995) Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. J Clin Investig 96:2017–2025
Pagotto U, Arzberger T, Hopfner U, Weindl A, Stalla GK (1995) Cellular localization of endothelin receptor mRNAs (ETA and ETB) in brain tumors and normal human brain. J Cardiovasc Pharmacol 26(Suppl 3):S104–S106
Yamaga S, Tsutsumi K, Niwa M, Kitagawa N, Anda T, Himeno A, Khalid H, Taniyama K, Shibata S (1995) Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography. Cell Mol Neurobiol 15:327–340
Beks JW, de Windt HL (1988) The recurrence of supratentorial meningiomas after surgery. Acta Neurochir (Wien) 95:3–5
Harland SP, Kuc RE, Pickard JD, Davenport AP (1998) Expression of endothelin (A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery 43:890–898 (discussion 898–899)
Laurendeau I, Ferrer M, Garrido D, D’Haene N, Ciavarelli P, Basso A, Vidaud M, Bieche I, Salmon I, Szijan I (2010) Gene expression profiling of the Hedgehog signaling pathway in human meningiomas. Mol Med 16:262–270
Mawrin C, Sasse T, Kirches E, Kropf S, Schneider T, Grimm C, Pambor C, Vorwerk CK, Firsching R, Lendeckel U, Dietzmann K (2005) Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 11:4074–4082
Cuevas IC, Slocum AL, Jun P, Costello JF, Bollen AW, Riggins GJ, McDermott MW, Lal A (2005) Meningioma transcript profiles reveal deregulated Notch signaling pathway. Cancer Res 65:5070–5075
Baia GS, Stifani S, Kimura ET, McDermott MW, Pieper RO, Lal A (2008) Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia (N Y) 10:604–612
Adams EF, Todo T, Schrell UM, Thierauf P, White MC, Fahlbusch R (1991) Autocrine control of human meningioma proliferation: secretion of platelet-derived growth-factor-like molecules. Int J Cancer 49:398–402
Jensen RL, Lee YS, Guijrati M, Origitano TC, Wurster RD, Reichman OH (1995) Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: part II—additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery 37:937–946 (discussion 946–947)
Johnson MD, Horiba M, Winnier AR, Arteaga CL (1994) The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas. Hum Pathol 25:146–153
Maxwell M, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN (1990) Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer 46:16–21
Schrell UM, Gauer S, Kiesewetter F, Bickel A, Hren J, Adams EF, Fahlbusch R (1995) Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop. J Neurosurg 82:600–607
Takahashi JA, Suzui H, Yasuda Y, Ito N, Ohta M, Jaye M, Fukumoto M, Oda Y, Kikuchi H, Hatanaka M (1991) Gene expression of fibroblast growth factor receptors in the tissues of human gliomas and meningiomas. Biochem Biophys Res Commun 177:1–7
Todo T, Adams EF, Fahlbusch R (1993) Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. J Neurosurg 78:463–469
Todo T, Adams EF, Fahlbusch R, Dingermann T, Werner H (1996) Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor. J Neurosurg 84:852–858 (discussion 858–859)
Ueba T, Takahashi JA, Fukumoto M, Ohta M, Ito N, Oda Y, Kikuchi H, Hatanaka M (1994) Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues. Neurosurgery 34:221–225 (discussion 225–226)
Wang JL, Nister M, Hermansson M, Westermark B, Ponten J (1990) Expression of PDGF beta-receptors in human meningioma cells. Int J Cancer 46:772–778
Weisman AS, Raguet SS, Kelly PA (1987) Characterization of the epidermal growth factor receptor in human meningioma. Cancer Res 47:2172–2176
Jensen RL, Origitano TC, Lee YS, Weber M, Wurster RD (1995) In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36:365–373 (discussion 373–374)
Johnson MD, Okedli E, Woodard A, Toms SA, Allen GS (2002) Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells. J Neurosurg 97:668–675
Johnson MD, Woodard A, Kim P, Frexes-Steed M (2001) Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells. J Neurosurg 94:293–300
Johnson MD, Okediji E, Woodard A (2004) Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways. J Neurooncol 66:9–16
Johnson MD, Federspiel CF, Gold LI, Moses HL (1992) Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells. Am J Pathol 141:633–642
Bajetto A, Barbieri F, Pattarozzi A, Dorcaratto A, Porcile C, Ravetti JL, Zona G, Spaziante R, Schettini G, Florio T (2007) CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neurooncology 9:3–11
Johnson MD, O’Connell MJ, Vito F, Pilcher W (2009) Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol 68:1177–1183
Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A (1997) Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 87:315–323
Hasegawa-Sasaki H, Lutz F, Sasaki T (1988) Pathway of phospholipase C activation initiated with platelet-derived growth factor is different from that initiated with vasopressin and bombesin. J Biol Chem 263:12970–12976
Karin M (1992) Signal transduction from cell surface to nucleus in development and disease. FASEB J 6:2581–2590
Schlessinger J, Ullrich A, Honegger AM, Moolenaar WH (1988) Signal transduction by epidermal growth factor receptor. Cold Spring Harb Symp Quant Biol 53(Pt 1):515–519
Benjamin CW, Connor JA, Tarpley WG, Gorman RR (1988) NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization. Proc Natl Acad Sci USA 85:4345–4349
Berridge MJ, Taylor CW (1988) Inositol trisphosphate and calcium signaling. Cold Spring Harb Symp Quant Biol 53(Pt 2):927–933
Bishayee S, Majumdar S, Khire J, Das M (1989) Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation. J Biol Chem 264:11699–11705
Meisenhelder J, Suh PG, Rhee SG, Hunter T (1989) Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57:1109–1122
Obermeier A, Tinhofer I, Grunicke HH, Ullrich A (1996) Transforming potentials of epidermal growth factor and nerve growth factor receptors inversely correlate with their phospholipase C gamma affinity and signal activation. EMBO J 15:73–82
Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2007) Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 109:588–597
Jensen RL, Petr M, Wurster RD (2000) Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation. Neurosurgery 46:692–702 (discussion 702–703)
Todo T, Fahlbusch R (1994) Accumulation of inositol phosphates in low-passage human meningioma cells following treatment with epidermal growth factor. J Neurosurg 80:890–896
Cole K, Kohn E (1994) Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev 13:31–44
Felder CC, Ma AL, Liotta LA, Kohn EC (1991) The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J Pharmacol Exp Ther 257:967–971
Sortino MA, Yasumoto T, Cronin MJ (1990) Maitotoxin increases free calcium and inositol phosphates in rat anterior pituitary cells. Pharmacol Res 22(Suppl 1):73–74
Kohn EC, Liotta LA (1990) L651582: a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 82:54–60
Sutherland C, Walsh MP (1989) Activation of protein kinase C by the dihydropyridine calcium channel blocker, felodipine. Biochem Pharmacol 38:1263–1270
Ragel BT, Jensen RL, Couldwell WT (2007) Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors. Neurosurg Focus 23(4):E7
Acknowledgments
The authors thank Kristin Kraus, M.Sc., and Shirley McCartney, Ph.D., for their editorial assistance in preparing this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ragel, B.T., Jensen, R.L. Aberrant signaling pathways in meningiomas. J Neurooncol 99, 315–324 (2010). https://doi.org/10.1007/s11060-010-0381-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-010-0381-8